This human antibody can bind to osteopontin with high affinity and effectively neutralize both human and mouse osteopontin. It also may provide a method for treating various cancers.
Figure 1 The effect of MOR-6993 on tumor weight in a preclinical model of breast cancer.
Figure 2 The effect of MOR-6993 on metastasis in a preclinical model of breast cancer.
Figure 3 The neutralization of mouse osteopontin by MOR-6990 and MOR-6993.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0258CL | Anti-Human SPP1 Recombinant Antibody (mAb 4-4-2) | ELISA, WB | |
TAB-0259CL | Anti-Human SPP1 Recombinant Antibody (mAb 7-5-4) | ELISA, WB | |
TAB-0260CL | Anti-Human SPP1 Recombinant Antibody (mAb 9-3-1) | ELISA, WB | |
TAB-0261CL | Anti-Human SPP1 Recombinant Antibody (mAb 21-5-4) | ELISA, WB | |
TAB-0843CL-S(P) | Anti-Human SPP1 Recombinant Antibody scFv Fragment (2K1) | sELISA |
There are currently no Customer reviews or questions for TAB-0848CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.